According to Ypsomed's latest financial reports the company's current EPS (TTM) is $10.49. In 2024 the company made an earnings per share (EPS) of $10.49 an increase over its 2023 EPS that were of $6.90.
Year | EPS | Change |
---|---|---|
2024 | $10.49 | 52.16% |
2023 | $6.90 | 110.93% |
2022 | $3.27 | 307.14% |
2021 | $0.80 | -49.58% |
2020 | $1.59 | -79.79% |
2019 | $7.88 | 10.54% |
2018 | $7.13 | 18.22% |
2017 | $6.03 | 24.64% |
2016 | $4.84 | 84.88% |
2015 | $2.62 | 30.72% |
2014 | $2.00 | 790.09% |
2013 | $0.22 | -81.6% |
2012 | $1.22 | 58.82% |
2011 | $0.77 | -37.57% |
2010 | $1.23 | -63.35% |
2009 | $3.36 | -14.15% |
2008 | $3.92 | 1106.25% |
2007 | $0.32 | -94.79% |
2006 | $6.24 | 30.04% |
2005 | $4.80 | 195.59% |
2004 | $1.62 | -99.97% |
2003 | $5,745 | 611303.59% |
2002 | $0.94 |